quinoxaline derivatives

The antibacterial activity of certain quinoxaline 1:4-dioxides has been described by McIlwain (1943), Wiedling (1945), Frisk (1946), and Iland (1948), and previous papers from this Laboratory described their action on Entamoeba hi8tolytica (Jones, Landquist & Stewart, 1953), and on viruses of the lymphogranuloma-psittacosis group (Hurst et al. 1953). We have found that quinoxaline 1:4dioxides s...

متن کامل

(Phenyl)(3-phenylsulfonyl-1,2-dihydropyrrolo[1,2-a]quinoxalin-1-yl)methanone

2011

Yaşar Dürüst Akın Sağırlı Frank R. Fronczek

In the title mol-ecule, C(24)H(18)N(2)O(3)S, the 13-atom ring system comprising the quinoxaline and fused five-membered ring exhibits an r.m.s. deviation from coplanarity of 0.039 Å, with a maximum deviation of 0.0710 (10) Å for the PhCO-bearing C atom of the five-membered ring. The 10-membered C(8)N(2) quinoxaline ring system has an r.m.s. deviation from coplanarity of 0.022 Å, with a maximum ...

متن کامل

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید

Synthesis of Benzo[g]quinoxaline-5,10-dione Based Pyridine Derivatives and their Antimycobacterial Activity

Formation of quinoxaline and benzimidazole derivatives from methylpentoses by the reaction with O-phenylenediamine.

New Amide Derivatives of Quinoxaline 1,4-di-N-Oxide with Leishmanicidal and Antiplasmodial Activities

One-Pot Synthesis of Pyrrolo[1,2-a]quinoxaline Derivatives through Copper-Catalyzed Cascade Reactions

In Vitro and In Vivo Activities of 2,3-Diarylsubstituted Quinoxaline Derivatives against Leishmania amazonensis

2-Hydroxymethyl-3-methylquinoxaline 1:4-dioxide: a metabolite of 2:3-dimethylquinoxaline 1:4-dioxide active against gram-negative bacteria.

(Phenyl)(3-phenylsulfonyl-1,2-dihydropyrrolo[1,2-a]quinoxalin-1-yl)methanone

Understanding the mechanism of action of pyrrolo[3,2-b]quinoxaline-derivatives as kinase inhibitors

Synthesis and Evaluation of New Quinoxaline Derivatives of Dehydroabietic Acid as Potential Antitumor Agents

IN SILICO DESIGN OF QUINOXALINE BEARING THIAZOLIDINONE DERIVATIVES AS PPARγ AGONIST IN DIABETES MELLITUS